Publications
AVAC publications aim to translate the complex
issues of biomedical HIV prevention research
for a range of audiences. We have materials
that explain current scientific issues in
simple language, and other documents that
explore the issues and expertise of communities
that are affected by and asked to participate
in clinical trials.
AVAC Report
For fifteen years, AVAC has published an annual review of biomedical prevention research. Over this period, the focus of the AVAC Report has expanded from AIDS vaccine research alone to the full spectrum of options, including pre-exposure prophylaxis, HSV-2 treatment, microbicides and male circumcision. This comprehensive document reviews progress, makes recommendations and analyses emerging issues.
Visit the AVAC Reports page for summaries of and links to this year's and past AVAC reports.
PxWire
Px Wire is AVAC's
quarterly update on biomedical HIV prevention
research. Each
issue includes a comprehensive timeline of
ongoing efficacy trials around the
world and a map showing where in the world
these trials are happening. Each
issue also includes updates on news, emerging
issues and upcoming events.
Click here for more information and to download the latest issue.
Anticipating and Understanding Results
The Anticipating and
Understanding
Results series provides timely analysis
of emerging or recently-announced
trial results. Past publications in the series
have explored the trials of male
circumcision for HIV prevention, pre-exposure
prophylaxis and the Thai
prime-boost vaccine efficacy trial.
PrEP Primer
This primer provides an
introduction to pre-exposure prophylaxis
(PrEP)
research for HIV prevention, including basic
information on PrEP
strategies being studied, the scientific
rationale for PrEP, the state
of the research, who is involved in PrEP, what
additional research may
be needed, and how to prepare for upcoming
trial results.
Making Medical Male Circumcision Work for Women
This report is one component of ongoing civil
society work in countries to elevate women’s
concerns and to ensure that the rollout of
medical male circumcision as an HIV prevention
strategy is beneficial and safe for women. Over
the next year, Women's HIV Prevention Tracking
Project (WHiPT) teams will execute advocacy
plans based on the findings reported here.
Click here for individual country reports, a two-page summary, and more related materials.
Microbicides: Ways Forward
Microbicides: Ways Forward is the final in a series of strategy documents put out by the Alliance for Microbicide Development (AMD). In 2009, the Alliance surveyed a number of microbicides experts and key stakeholders in the field in an effort to identify area of progress, obstacles that remain and priorities for the field. These conversations and insights inform much of the new report, which concludes with nine key recommendations for moving the microbicide field forward. The Alliance officially closed at the end of 2009 and this new report is one of many key AMD resources that we will be integrating into our continually expanding education, outreach, advocacy and policy work.
AIDS Vaccine Handbook
Published in 2005
the AIDS Vaccine Handbook (second
edition) provides an overview of the key
scientific, policy, social, ethical and
economic challenges related to AIDS vaccine
development. The easy-to-read,
lively essays are written by community
educators and advocates, trial staff,
volunteers, scientists, policy-makers, and
journalists.
Visit the AIDS Vaccine Handbook page to view an electronic version of the handbook and to get ordering information.
Resource Tracking
The HIV Vaccines and
Microbicides Resource Tracking Working Group
was established in 2004 to generate and
disseminate high-quality, detailed and
comparable data on global investments in
preventive HIV vaccine and microbicide research
and development (R&D), and policy and
advocacy activities. In 2006, the Working
Group expanded its tracking efforts to include
other experimental HIV prevention options, such
as adult male circumcision, HSV-2 suppression
and pre-exposure prophylaxis (PrEP). Since
2004, the Working Group has published an annual
report on HIV prevention research and
development. Each report tracks investments
from the previous year as well as the trends
back to 2000. By identifying and tracking the
resources invested in HIV prevention research
and development these reports are intended to
serve as a key to understanding and evaluating
the global response to the HIV/AIDS pandemic.
The Good Participatory Practice (GPP) Guidelines for Biomedical HIV Prevention Trials, 2nd Edition (2011)
The good
participatory practice (GPP) guidelines are
intended to provide trial funders, sponsors,
and implementers with systematic guidance on
how to effectively engage with all stakeholders
in the design and conduct of biomedical HIV
prevention trials.
For more information visit www.avac.org/gpp.
Communications Handbook for Clinical Trials
This handbook
provides practical guidance to clinical trial
staff and research partners on how to
anticipate and respond to the special
communications challenges posed by the conduct
of clinical research. Organized to correspond
to the chronological steps involved in
conducting research, this guide focuses on the
various communications skills that are needed
throughout the course of a trial.
For more information and to download a PDF of the book or its individual chapters, click here.
Finding Your Way
Developed by AVAC in
partnership with the International Council of
AIDS Service Organizations (ICASO) in 2005,
this guide provides an introduction to the
ethical principles raised in preventive
HIV vaccine research and development, and
examples of some of the actions taken to honor
those principles.
AVAC Report
For fifteen years, AVAC has published an annual review of biomedical prevention research. Over this period, the focus of the AVAC Report has expanded from AIDS vaccine research alone to the full spectrum of options, including pre-exposure prophylaxis, HSV-2 treatment, microbicides and male circumcision. This comprehensive document reviews progress, makes recommendations and analyses emerging issues.
Visit the AVAC Reports page for summaries of and links to this year's and past AVAC reports.
PxWire
Click here for more information and to download the latest issue.
Anticipating and Understanding Results
PrEP Primer
Making Medical Male Circumcision Work for Women
Click here for individual country reports, a two-page summary, and more related materials.
Microbicides: Ways Forward
Microbicides: Ways Forward is the final in a series of strategy documents put out by the Alliance for Microbicide Development (AMD). In 2009, the Alliance surveyed a number of microbicides experts and key stakeholders in the field in an effort to identify area of progress, obstacles that remain and priorities for the field. These conversations and insights inform much of the new report, which concludes with nine key recommendations for moving the microbicide field forward. The Alliance officially closed at the end of 2009 and this new report is one of many key AMD resources that we will be integrating into our continually expanding education, outreach, advocacy and policy work.
AIDS Vaccine Handbook
Visit the AIDS Vaccine Handbook page to view an electronic version of the handbook and to get ordering information.
Resource Tracking
The Good Participatory Practice (GPP) Guidelines for Biomedical HIV Prevention Trials, 2nd Edition (2011)
For more information visit www.avac.org/gpp.
Communications Handbook for Clinical Trials
For more information and to download a PDF of the book or its individual chapters, click here.
Finding Your Way